Medgenics Announces First Patient Implanted in Phase 1/2 Clinical Trial of MDGN-201 (EPODURE)
June 05, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, June 5, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic...
Medgenics Reports First Quarter Financial Results
May 08, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, May 8, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic...
Medgenics Awarded $2.2 Million Grant From the Israeli Office of the Chief Scientist
April 15, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, April 15, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) (LSE:MEDU) (LSE:MEDG), the developer of BioPump(TM) a novel technology for the sustained production...
Medgenics Announces Results of 2014 Annual Meeting of Stockholders
April 09, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, April 9, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) (AIM:MEDU) (AIM:MEDG), the developer of Biopump(TM) a novel technology for the sustained production and...
Medgenics, Inc. to Present at the 26th Annual ROTH Capital Growth Conference
March 05, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, March 5, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) (AIM:MEDU) (AIM:MEDG), the developer of BioPump™, a novel platform technology for the sustained...
Medgenics Reports 2013 Financial Results
February 20, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT: MDGN) (LSE:MEDU) (LSE:MEDG), the developer of a novel platform technology for the sustained production and...